Polypoidal Choroidal Vasculopathy (PCV): Clinical Trials

2 trials for Polypoidal Choroidal Vasculopathy (PCV), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 2

Follow Polypoidal Choroidal Vasculopathy (PCV): new trials by email Literature Review of Polypoidal Choroidal Vasculopathy (PCV) trials Research Report on Polypoidal Choroidal Vasculopathy (PCV)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial
aflibercept 8 mg - Polypoidal Choroidal Vasculopathy, Polypoidal Choroidal Vasculopathy (PCV)
Phase 3RecruitingYeungnam University College of Medicine502026-12-242026-02-05
Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy
Faricimab Injection [Vabysmo] - Polypoidal Choroidal Vasculopathy (PCV), Age Related Macular Degeneration
Phase 3RecruitingYeungnam University College of Medicine502026-03-012026-03-10

Narrower conditions

Polypoidal Choroidal Vasculopathy (2)  ·  Macular Degeneration (1)

Broader conditions

Choroid Diseases (2)  ·  Choroidal Neovascularization (2)  ·  Eye Diseases (2)  ·  Metaplasia (2)  ·  Neovascularization, Pathologic (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Uveal Diseases (2)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)

Interventions

aflibercept (1)  ·  faricimab (1)

Sponsors

Yeungnam University College of Medicine (2)

Countries

South Korea (2)